ES2115115T3 - Benzoilguanidinas sustituidas con urea, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene. - Google Patents
Benzoilguanidinas sustituidas con urea, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.Info
- Publication number
- ES2115115T3 ES2115115T3 ES94112383T ES94112383T ES2115115T3 ES 2115115 T3 ES2115115 T3 ES 2115115T3 ES 94112383 T ES94112383 T ES 94112383T ES 94112383 T ES94112383 T ES 94112383T ES 2115115 T3 ES2115115 T3 ES 2115115T3
- Authority
- ES
- Spain
- Prior art keywords
- medicinal product
- benzoilguanidines
- urea
- substituted
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C335/22—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
SE DESCRIBEN NUEVAS BENZOIL GUANIDINAS DE LA FORMULA I CON R(1), R(3) O R(4) IGUAL A OXIGENO, AZUFRE, R(6), R(7) Y R(8) IGUAL A H, (PERFLUOR)ALQU(EN)IL, DONDE R(7) Y R(8) PUEDEN SER TAMBIEN CONJUNTAMENTE 4 O 5 GRUPOS METILENO, QUE SON RESPECTIVAMENTE SUSTITUYENTES PERMANECIENTES R(1) HASTA R(5) H, HAL, (FLUOR)ALQU(EN)IL, CN, NO2, NR(16)R(17). LOS COMPUESTOS COMO CONSECUENCIA DE SUS PROPIEDADES FARMACOLOGICAS SON APROPIADOS COMO MEDICAMENTOS ANTIARRITMICOS CON COMPONENTES CARDIOPROTECTIVOS PARA PROFILAXIS DEL INFARTO Y EL TRATAMIENTO DE INFARTO, ASI COMO TRATAMIENTO DE LA ANGINA DE PECHO DE FORMA SOBRESALIENTE, CON LO CUAL TIENEN EFECTO TAMBIEN PREVENTIVO EN LOS PROCESOS PATOPSICOLOGICOS MEDIANTE LA GENERACION DE DAÑOS INDUCIDOS ISQUEMICOS, INHIBIENDO O EVITANDO FUERTEMENTE LAS ARRITMIAS CARDIACAS INDUCIDAS ISQUEMICAS. SE OBTIENEN MEDIANTE TRANSFORMACION DE UN COMPUESTO DE LA FORMULA II DONDE L ES UN GRUPO SUSTITUIBLE FACILMENTE NUCLEOFILO, CON GUANIDINA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4327244A DE4327244A1 (de) | 1993-08-13 | 1993-08-13 | Harnstoffsubstituierte Benzoylguandine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2115115T3 true ES2115115T3 (es) | 1998-06-16 |
Family
ID=6495131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94112383T Expired - Lifetime ES2115115T3 (es) | 1993-08-13 | 1994-08-08 | Benzoilguanidinas sustituidas con urea, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene. |
Country Status (16)
Country | Link |
---|---|
US (1) | US5559153A (es) |
EP (1) | EP0638548B1 (es) |
JP (1) | JP3647901B2 (es) |
CN (1) | CN1060763C (es) |
AT (1) | ATE165342T1 (es) |
AU (1) | AU683273B2 (es) |
CA (1) | CA2130031C (es) |
DE (2) | DE4327244A1 (es) |
DK (1) | DK0638548T3 (es) |
ES (1) | ES2115115T3 (es) |
FI (1) | FI943716A (es) |
HU (1) | HU217628B (es) |
IL (1) | IL110625A (es) |
NO (1) | NO300680B1 (es) |
NZ (1) | NZ264216A (es) |
ZA (1) | ZA946074B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL109570A0 (en) * | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
DE4412334A1 (de) * | 1994-04-11 | 1995-10-19 | Hoechst Ag | Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
IL114670A0 (en) * | 1994-08-05 | 1995-11-27 | Fujisawa Pharmaceutical Co | Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof |
US5847172A (en) * | 1995-06-07 | 1998-12-08 | Magainin Pharmaceuticals Inc. | Certain aminosterol compounds and pharmaceutical compositions including these compounds |
US5994336A (en) * | 1995-06-07 | 1999-11-30 | Magainin Pharmaceuticals Inc. | Method of inhibiting proliferation of cells by administering an aminosterol compound |
DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
PL316439A1 (en) * | 1995-11-20 | 1997-05-26 | Hoechst Ag | Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such |
DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
JPH11502876A (ja) * | 1996-01-26 | 1999-03-09 | 藤沢薬品工業株式会社 | グアニジン誘導体 |
DE19603425A1 (de) * | 1996-01-31 | 1997-08-07 | Hoechst Ag | Substituierte Diaryldicarbonsäure-diguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
US6820824B1 (en) | 1998-01-14 | 2004-11-23 | 3M Innovative Properties Company | Apparatus for spraying liquids, disposable containers and liners suitable for use therewith |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3780027A (en) * | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
GB1311432A (en) * | 1971-01-07 | 1973-03-28 | Ici Ltd | Guanidine derivatives their preparation and antiviral compositions containing them |
DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
US5276907A (en) * | 1991-01-07 | 1994-01-04 | Motorola Inc. | Method and apparatus for dynamic distribution of a communication channel load in a cellular radio communication system |
DE59302959D1 (de) * | 1992-02-15 | 1996-07-25 | Hoechst Ag | 3,5-Substituierte Benzoylguanidine, mit antiarrythmischer Wirkung und inhibierender Wirkung auf die Proliferationen von Zellen |
-
1993
- 1993-08-13 DE DE4327244A patent/DE4327244A1/de not_active Withdrawn
-
1994
- 1994-08-08 ES ES94112383T patent/ES2115115T3/es not_active Expired - Lifetime
- 1994-08-08 DE DE59405764T patent/DE59405764D1/de not_active Expired - Lifetime
- 1994-08-08 DK DK94112383T patent/DK0638548T3/da active
- 1994-08-08 AT AT94112383T patent/ATE165342T1/de not_active IP Right Cessation
- 1994-08-08 EP EP94112383A patent/EP0638548B1/de not_active Expired - Lifetime
- 1994-08-11 CN CN94109503A patent/CN1060763C/zh not_active Expired - Fee Related
- 1994-08-11 IL IL11062594A patent/IL110625A/en not_active IP Right Cessation
- 1994-08-11 AU AU70223/94A patent/AU683273B2/en not_active Ceased
- 1994-08-11 US US08/289,674 patent/US5559153A/en not_active Expired - Lifetime
- 1994-08-11 FI FI943716A patent/FI943716A/fi unknown
- 1994-08-11 NZ NZ264216A patent/NZ264216A/en unknown
- 1994-08-12 ZA ZA946074A patent/ZA946074B/xx unknown
- 1994-08-12 CA CA002130031A patent/CA2130031C/en not_active Expired - Fee Related
- 1994-08-12 HU HU9402346A patent/HU217628B/hu not_active IP Right Cessation
- 1994-08-12 JP JP18972594A patent/JP3647901B2/ja not_active Expired - Fee Related
- 1994-08-12 NO NO942985A patent/NO300680B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
DE59405764D1 (de) | 1998-05-28 |
AU7022394A (en) | 1995-02-23 |
JP3647901B2 (ja) | 2005-05-18 |
EP0638548B1 (de) | 1998-04-22 |
CN1060763C (zh) | 2001-01-17 |
ZA946074B (en) | 1995-03-20 |
NO300680B1 (no) | 1997-07-07 |
CA2130031C (en) | 2005-11-15 |
IL110625A (en) | 1999-03-12 |
EP0638548A1 (de) | 1995-02-15 |
FI943716A (fi) | 1995-02-14 |
NO942985L (no) | 1995-02-14 |
JPH0776566A (ja) | 1995-03-20 |
IL110625A0 (en) | 1994-11-11 |
NO942985D0 (no) | 1994-08-12 |
HU217628B (hu) | 2000-03-28 |
NZ264216A (en) | 1995-10-26 |
ATE165342T1 (de) | 1998-05-15 |
DK0638548T3 (da) | 1998-11-23 |
CN1111618A (zh) | 1995-11-15 |
HUT71816A (en) | 1996-02-28 |
US5559153A (en) | 1996-09-24 |
HU9402346D0 (en) | 1994-10-28 |
FI943716A0 (fi) | 1994-08-11 |
CA2130031A1 (en) | 1995-02-14 |
DE4327244A1 (de) | 1995-02-16 |
AU683273B2 (en) | 1997-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2115115T3 (es) | Benzoilguanidinas sustituidas con urea, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene. | |
ES2040838T3 (es) | Compuestos piperazinil-heterociclicos. | |
ES2112332T3 (es) | Derivados de substitucion de oxigeno de productos de adicion de nucleofilo-oxido nitrico utilizados como promedicamentos donadores de oxido nitrico. | |
NO923235D0 (no) | Cykliske iminderivater, samt fremgangsmaate for fremstilling av slike | |
MX9803954A (es) | Derivados de aminoacidos, composiciones farmaceuticas que contienen estos compuestos y procesos para prepararlos. | |
PA8539801A1 (es) | Derivados del ácido isoftálico como inhibidores de metaloproteinasas de la matriz | |
ES2058614T3 (es) | 1,2-ciclohexilaminoarilaminadas utiles como agentes analgesicos. | |
MX9302448A (es) | Derivados iminicos ciclicos, procedimientos para su preparacion y medicamentos que contienen estos compuestos. | |
AR040201A1 (es) | Benzoilguanidinas cicloalquilderivadas fluoradas, su uso como medicamento y medicamentos que las contienen | |
PT96946A (pt) | Processo para a preparacao de agentes colinergicos azabiciclo e azaciclo oxima e amina e de composicoes farmaceuticas que os contem | |
ES2136291T3 (es) | Derivados de pirimidina. | |
UY27835A1 (es) | Derivados de isoindolona, proceso de preparacion y compuestos intermedios de este proceso, su uso como medicamentos, y composiciones farmaceuticas que los contienen. | |
DE69911935D1 (de) | Granulatimide-derivate zur behandlung von krebs | |
ES2045189T3 (es) | Nuevos agentes anti-arritmicos i. | |
MX9400070A (es) | Compuestos heterociclicos, un procedimiento para prepararlos, su uso y composiciones farmaceuticas que los contienen. | |
ES2167021T3 (es) | Derivados de acido 4-bifenil-4-hidroxibutirico sustituidos como inhibidores de metaloproteasa de matriz. | |
ES2059931T3 (es) | Procedimiento para el tratamiento de la hipertrofia e hiperplasia cardiaca asi como vascular. | |
ES2066755T3 (es) | Derivados de aminoacidos inhibidores de renina. | |
NO961521L (no) | Antiarytmiske og kardiobeskyttende substituerte indenoylguanidiner | |
ZA875821B (en) | Diselenobis benzoic acid amides of primary heterocyclic amines,process for producing the same and pharmaceutical compounds comprising the same | |
ES2145306T3 (es) | Nitro-benzamidas utiles como agentes anti-arritmicos. | |
AR007299A1 (es) | 1-naftoilguanidinas sustituidas, procedimiento para su preparacion, su empleo para la preparacion de un medicamento y agente curativo y terapeuticoque las contiene | |
PT83929B (pt) | Processo de preparacao de 3-benzazepinas substituidas por sulfinilo e sulfonilo e das composicoes farmaceuticas que as contem | |
ES2040744T3 (es) | Un procedimiento para preparar derivados de 1,2,4-triazinona. | |
ES2188847T3 (es) | Derivados 9-n-etenil de 9(s)-eritromicilamina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 638548 Country of ref document: ES |